Organovo (NASDAQ:ONVO) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO) in a report released on Saturday morning. The firm issued a sell rating on the medical research company’s stock.

Organovo Stock Performance

Shares of NASDAQ ONVO opened at $0.39 on Friday. The stock has a market cap of $5.93 million, a P/E ratio of -0.36 and a beta of 0.54. The firm has a 50 day moving average price of $0.38 and a 200 day moving average price of $0.45. Organovo has a 52-week low of $0.32 and a 52-week high of $1.74.

Organovo Company Profile

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.